Independent of early biological therapy, time-to-event analysis also showed transmural healing was associated with reduced time to bowel damage progression (aHR = 0.28; 95% CI, 0.1-0.79), CD ...

Endologix LLC reported 12-month results from the second of two studies of a fully percutaneous, transmural arterial bypass therapy for treating peripheral arterial disease. Presented at this month's ...